SK285130B6 - Farmaceutický prostriedok obsahujúci derivát [(aminoiminometyl)amino]alkánkarboxamidu, tento derivát a spôsob jeho prípravy a použitie tohto derivátua prostriedku - Google Patents
Farmaceutický prostriedok obsahujúci derivát [(aminoiminometyl)amino]alkánkarboxamidu, tento derivát a spôsob jeho prípravy a použitie tohto derivátua prostriedku Download PDFInfo
- Publication number
- SK285130B6 SK285130B6 SK984-2001A SK9842001A SK285130B6 SK 285130 B6 SK285130 B6 SK 285130B6 SK 9842001 A SK9842001 A SK 9842001A SK 285130 B6 SK285130 B6 SK 285130B6
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- carbon atoms
- alkylthio
- substituted
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9900194A FR2788275B1 (fr) | 1999-01-11 | 1999-01-11 | ((aminoiminomethyl)amino) alcane carboxamides et leurs applications en therapeutique |
PCT/EP1999/010468 WO2000042001A1 (en) | 1999-01-11 | 1999-12-30 | ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
SK9842001A3 SK9842001A3 (en) | 2001-12-03 |
SK285130B6 true SK285130B6 (sk) | 2006-07-07 |
Family
ID=9540749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK984-2001A SK285130B6 (sk) | 1999-01-11 | 1999-12-30 | Farmaceutický prostriedok obsahujúci derivát [(aminoiminometyl)amino]alkánkarboxamidu, tento derivát a spôsob jeho prípravy a použitie tohto derivátua prostriedku |
Country Status (27)
Country | Link |
---|---|
US (1) | US6518458B1 (id) |
EP (1) | EP1140803B1 (id) |
JP (1) | JP4567889B2 (id) |
KR (1) | KR100630291B1 (id) |
CN (1) | CN1182109C (id) |
AR (1) | AR022221A1 (id) |
AT (1) | ATE252553T1 (id) |
AU (1) | AU760147B2 (id) |
BR (1) | BR9916858A (id) |
CA (1) | CA2359454C (id) |
CZ (1) | CZ20012482A3 (id) |
DE (1) | DE69912315T2 (id) |
DK (1) | DK1140803T3 (id) |
EE (1) | EE200100363A (id) |
ES (1) | ES2207325T3 (id) |
FR (1) | FR2788275B1 (id) |
HK (1) | HK1041689B (id) |
HU (1) | HUP0200023A3 (id) |
ID (1) | ID29586A (id) |
IL (1) | IL144225A0 (id) |
NO (1) | NO20013420D0 (id) |
NZ (1) | NZ513467A (id) |
PT (1) | PT1140803E (id) |
RU (1) | RU2236401C2 (id) |
SK (1) | SK285130B6 (id) |
WO (1) | WO2000042001A1 (id) |
ZA (1) | ZA200106606B (id) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005237764B2 (en) | 2004-05-05 | 2011-11-24 | Silence Therapeutics Gmbh | Lipids, lipid complexes and use thereof |
US8852472B2 (en) | 2004-12-27 | 2014-10-07 | Silence Therapeutics Gmbh | Coated lipid complexes and their use |
TW200808705A (en) * | 2006-06-15 | 2008-02-16 | Sanofi Aventis | Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
CN102321626B (zh) * | 2006-07-21 | 2014-12-10 | 赛伦斯治疗有限公司 | 用于抑制蛋白激酶3表达的方法 |
US8350077B2 (en) * | 2008-12-24 | 2013-01-08 | Vertex Closed Joint Stock Company | Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1153424A (en) * | 1965-04-15 | 1969-05-29 | Horlicks Ltd | Pharmaceutical Compositions |
US5654451B1 (en) * | 1993-01-14 | 2000-02-22 | Magainin Pharma | Amino acids and peptides having modified c-terminals and modified n-terminals |
JPH0841008A (ja) * | 1994-07-29 | 1996-02-13 | Ono Pharmaceut Co Ltd | 一酸化窒素合成酵素阻害剤 |
CA2217550A1 (en) * | 1996-10-22 | 1998-04-22 | F. Hoffmann-La Roche Ag | Cationic lipids for gene therapy |
US6395713B1 (en) * | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
DE19748697A1 (de) * | 1997-11-04 | 1999-05-06 | Basf Ag | Verfahren zur Herstellung von substituierten Guanidinderivaten |
-
1999
- 1999-01-11 FR FR9900194A patent/FR2788275B1/fr not_active Expired - Fee Related
- 1999-12-30 RU RU2001121195/04A patent/RU2236401C2/ru not_active IP Right Cessation
- 1999-12-30 EE EEP200100363A patent/EE200100363A/xx unknown
- 1999-12-30 ES ES99964687T patent/ES2207325T3/es not_active Expired - Lifetime
- 1999-12-30 DK DK99964687T patent/DK1140803T3/da active
- 1999-12-30 JP JP2000593569A patent/JP4567889B2/ja not_active Expired - Fee Related
- 1999-12-30 AU AU30443/00A patent/AU760147B2/en not_active Ceased
- 1999-12-30 BR BR9916858-8A patent/BR9916858A/pt not_active Application Discontinuation
- 1999-12-30 CA CA002359454A patent/CA2359454C/en not_active Expired - Fee Related
- 1999-12-30 PT PT99964687T patent/PT1140803E/pt unknown
- 1999-12-30 DE DE69912315T patent/DE69912315T2/de not_active Expired - Lifetime
- 1999-12-30 SK SK984-2001A patent/SK285130B6/sk not_active IP Right Cessation
- 1999-12-30 ID IDW00200101657A patent/ID29586A/id unknown
- 1999-12-30 KR KR1020017008794A patent/KR100630291B1/ko not_active IP Right Cessation
- 1999-12-30 AT AT99964687T patent/ATE252553T1/de not_active IP Right Cessation
- 1999-12-30 EP EP99964687A patent/EP1140803B1/en not_active Expired - Lifetime
- 1999-12-30 NZ NZ513467A patent/NZ513467A/en unknown
- 1999-12-30 HU HU0200023A patent/HUP0200023A3/hu unknown
- 1999-12-30 WO PCT/EP1999/010468 patent/WO2000042001A1/en active IP Right Grant
- 1999-12-30 CN CNB998155640A patent/CN1182109C/zh not_active Expired - Fee Related
- 1999-12-30 US US09/869,957 patent/US6518458B1/en not_active Expired - Lifetime
- 1999-12-30 CZ CZ20012482A patent/CZ20012482A3/cs unknown
- 1999-12-30 IL IL14422599A patent/IL144225A0/xx unknown
-
2000
- 2000-01-07 AR ARP000100063A patent/AR022221A1/es unknown
-
2001
- 2001-07-10 NO NO20013420A patent/NO20013420D0/no not_active Application Discontinuation
- 2001-08-10 ZA ZA200106606A patent/ZA200106606B/en unknown
-
2002
- 2002-05-07 HK HK02103446.2A patent/HK1041689B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU747663B2 (en) | Arylsulfonanilide ureas | |
HU201336B (en) | Process for production of a synthetic derivatives of distamicine and medical compositions containing them | |
US5872115A (en) | 2-ureido-benzamide derivatives | |
US3639477A (en) | Novel propoxyguanidine compounds and means of producing the same | |
US20210214356A1 (en) | Compounds and medicaments using same | |
NZ243959A (en) | Substituted pyrazine derivatives and pharmaceutical compositions thereof | |
CA2232090A1 (en) | Selective .beta.3 adrenergic agonists | |
SK285130B6 (sk) | Farmaceutický prostriedok obsahujúci derivát [(aminoiminometyl)amino]alkánkarboxamidu, tento derivát a spôsob jeho prípravy a použitie tohto derivátua prostriedku | |
US4258033A (en) | 2,6-Diaminonebularines | |
WO2008142623A2 (en) | Tumor necrosis factor - alpha inhibitors | |
US20040122040A1 (en) | Bicyclic guanidine derivatives and therapeutic uses thereof | |
EP0187639B1 (en) | Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient | |
US6683200B2 (en) | N-substituted-N′-substituted urea derivatives and pharmaceutical compositions containing the derivatives | |
KR960010353B1 (ko) | 티아디아졸 구아니딘 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
SK78599A3 (en) | New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications | |
EP4104902A1 (en) | Compound and drug containing same | |
JP2974791B2 (ja) | カルボキシイミダミド誘導体 | |
US20080293721A1 (en) | Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases | |
JP3930081B2 (ja) | 2−ウレイド−ベンズアミド誘導体 | |
JPS61280486A (ja) | N−フエニル−4−フエニル−1−ピペラジンカルボキシアミジン類 | |
JP2001181279A (ja) | ベンゾフラニルピロールカルボキシアミド誘導体 | |
SK284893B6 (sk) | Triazepinóny, spôsob ich výroby a ich terapeutické použitie | |
MXPA05000751A (es) | Compuestos con actividad anti-parasitaria y medicamentos que los contienen. | |
US20080021044A1 (en) | N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2h)-pyrazineacetamide | |
HU196590B (en) | Process for producing benzoyl ester derivatives and pharmaceutics comprising them as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20091230 |